Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) is a publicly traded company in the Unknown sector. Across all available filings, 34 corporate insiders have executed 279 transactions totaling $153.3M, demonstrating a bullish sentiment with $82.8M in net insider flow. The most recent transaction on Feb 2, 2026 involved a sale of 968 shares valued at $100.0K.
MIRM Insider Activity Summary
Who Is Buying MIRM Stock?
No significant insider buying has been recorded for MIRM in the recent period.
Who Is Selling MIRM Stock?
No significant insider selling has been recorded for MIRM in the recent period.
Is Mirum Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MIRM is bullish with an Insider Alignment Score of 77/100 and a net flow of $82.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MIRM Frequently Asked Questions
Understanding MIRM Insider Activity
Insider trading at Mirum Pharmaceuticals, Inc. (MIRM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 34 insiders are actively trading MIRM stock, having executed 279 transactions in the past 90 days. The most active insider is Michael G. Grey (Executive), who has made 15 transactions totaling $13.0M.
Related Tools
Track Mirum Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at MIRM file new Form 4 transactions